Page 30 - Compass Pathways News Today

/PRNewswire/ -- Today, Sound Mind Live announces the fourth annual Sound Mind Mental Health Music Festival, presented this year as a live, outdoor event at New...

Using psychedelics, such as magic mushrooms, to treat mood disorders—with Jerrold Rosenbaum, Stanley Cobb professor of psychiatry at Harvard Medical School

Oregon is set to become the first US state to legalize magic mushrooms, potentially unlocking a market for psychedelic treatments.

UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors. Dr Jenkins brings over 30 years of global industry

Investegate announcements from COMPASS Pathways, COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February 2022

Insider pored through 158 names to come up with our inaugural list of The Most Influential Women in Psychedelics.

2021 Y Combinator alum MindState Design Labs left stealth Thursday with $11.5 million in funding to develop psychedelics-based therapy drugs.

The clinical-stage biopharmaceutical company benefited from an increased interest in companies working on psychedelic therapies.

If you’ve hiked or camped in the Pacific Northwest, you might have walked by a tiny, brown mushroom that some say has the capacity to change your life.

Taking tiny doses of drugs like psilocybin, LSD, and ayahuasca is gaining popularity. But the benefits are still being investigated.